Carolina Contreras Cuevas/LinkedIn
Oct 24, 2025, 10:03
Debunking Myths with Carolina Contreras Cuevas: The AQUARIUS Trial That Had to Be Stopped
Carolina Contreras Cuevas, Hematologist, Medical Center and Interconsultant Physician at RedSalud CCHC, shared a post on LinkedIn:
“Debunking Myths.
The AQUARIUS study on the use of ASA + anticoagulant (VKA or DOAC) in patients with chronic coronary syndrome, already with a stent implanted for >6 months, and on anticoagulation for another reason.
Spoiler: The study had to be stopped early at 2.2 years.”
Read full paper here.
Stay informed with Hemostasis Today.
-
Nov 18, 2026, 01:45Shikha Jha: My Takeaways from the 4th GANSID International Congress
-
Nov 18, 2026, 01:34Zeeshan Ahmed Khattak: Treatment of Fever and Neutropenia in Hematology/Oncology and Hematopoietic Cell Transplant Patients
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support